Inter Parfums (IPAR) Q4 Earnings: What To Expect

StockStory
24 Feb
Inter Parfums (IPAR) Q4 Earnings: What To Expect

Fragrance and perfume company Inter Parfums (NASDAQ:IPAR) will be announcing earnings results tomorrow after market close. Here’s what you need to know.

Inter Parfums met analysts’ revenue expectations last quarter, reporting revenues of $424.6 million, up 15.4% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts’ EBITDA estimates.

Is Inter Parfums a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Inter Parfums’s revenue to grow 10.1% year on year to $362 million, improving from the 5.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.79 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Inter Parfums has missed Wall Street’s revenue estimates three times over the last two years.

Looking at Inter Parfums’s peers in the personal care segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Herbalife posted flat year-on-year revenue, beating analysts’ expectations by 0.6%, and Medifast reported a revenue decline of 37.7%, topping estimates by 4.2%. Herbalife traded up 42.5% following the results while Medifast was down 11.5%.

Read our full analysis of Herbalife’s results here and Medifast’s results here.

Stocks generally had a good 2024. The Fed fought high inflation and won without sending the economy into a recession, otherwise lovingly known as a soft landing. The US Central Bank is now cutting rates. That, plus the election of Donald Trump in November 2024, sent markets even higher, and while some of the personal care stocks have shown solid performance, the group has generally underperformed, with share prices down 2.6% on average over the last month. Inter Parfums is down 6.7% during the same time and is heading into earnings with an average analyst price target of $146.83 (compared to the current share price of $133.87).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10